COPENHAGEN, Denmark, September 20, 2022 – Bavarian Nordic A/S announced today that the board of directors has appointed Luc Debruyne as an observer to the board with the intent to. | September 20, 2022
COPENHAGEN, Denmark – May 4, 2022 - Bavarian Nordic A/S will announce its 2022 first quarter results on Monday, May 9, 2022. The management of Bavarian Nordic will host a conference call at. | May 4, 2022
In 2021,
DKK 1,900 million and
DKK 2,200 million and an EBITDA between
DKK 100 million and
DKK 300 million and
Key assumptions
Revenue:
The low end of the revenue range reflects a scenario where a lockdown due to COVID-19 continues beyond Q1 in key markets like the US and
Germany. The higher end of the revenue range reflects a scenario where a gradual reopening will happen in key markets during Q2 and where travel starts picking up again in Q3 and Q4 of 2021.
The smallpox and Ebola business are not expected to be impacted by COVID-19.
Research and development:
Research and development costs of approximately
Bavarian Nordic s shares jumped as much as 18% on Monday after the Danish firm reported encouraging data from its COVID-19 vaccine candidate, which is set to move to human trials shortly.. | March 12, 2021